First Year Real Life Experience With Intravitreal Brolucizumab for Treatment of Refractory Neovascular Age-Related Macular Degeneration

• Asıl Yazarlar: Alaa Din Abdin (Yazar), Wissam Aljundi (Yazar), Khalil El Jawhari (Yazar), Shady Suffo (Yazar), Isabel Weinstein (Yazar), Berthold Seitz (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Purpose: To assess the morphological and functional outcomes within the first year of treatment with intravitreal brolucizumab for refractory neovascular age-related macular degeneration (nAMD).Methods: This retrospective study included 21 eyes from 19 patients with refractory nAMD followed for 12 m...